Premium
Lipopolysaccharide (LPS) and zymosan‐resistant mutant isolated from a macrophage‐like cell line, WEHI‐3, with a defective response to LPS under serum‐free conditions
Author(s) -
Ohki Kazunori,
Amano Fumio,
Kohashi Osamu
Publication year - 2001
Publication title -
immunology and cell biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.999
H-Index - 104
eISSN - 1440-1711
pISSN - 0818-9641
DOI - 10.1046/j.1440-1711.2001.01037.x
Subject(s) - zymosan , mutant , lipopolysaccharide , cd14 , microbiology and biotechnology , biology , signal transduction , cell culture , macrophage , stimulation , immunology , biochemistry , flow cytometry , in vitro , endocrinology , gene , genetics
A LPS‐resistant mutant, W3SF‐1, was isolated from a murine macrophage‐like cell line, WEHI‐3. The W3SF‐1 mutant did not produce a significant amount of nitric oxide (NO) or TNF‐α even with high concentrations of LPS in the presence or absence of FCS, whereas the parental WEHI‐3 cells produced them in response to LPS. The parental cells expressed a significant level of TNF‐α mRNA after LPS stimulation, whereas the mutant cells did not. This defective response of the mutant cells to LPS was neither dependent on the concentration or chemical structure of LPS, nor on the time of LPS treatment. The mutant cells also showed a defective response to zymosan, suggesting that the defect in the mutant cells is common to LPS and zymosan in the signal transduction pathways. The parental and mutant cells showed similar levels of Mac1, F4/80 and CD14, suggesting that these surface markers of macrophages are not linked directly to the defective responses of the mutant to LPS. The treatment of mutant cells with IFN‐γ did not restore the defect of NO or TNF‐α production on LPS treatment. Binding experiments with 125 I‐labelled LPS showed a similar binding affinity for LPS in the parental and the mutant cells. These results suggest that the defect in the W3SF‐1 mutant cells may not reside in the LPS binding but rather in the early step of signal transduction pathways in the cells after LPS binding.